Consistent with this observation, in breast cancer cell lines and mouse xenografts, Apigenin suppressed the nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent antioxidant system through inhibition of PI3K/Akt axis [166]. Here, NFE2L2 is linked to breast cancer.